Top compounds associated with response to TMTC3


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib UHNBreast pan-cancer AAC -0.41 0.1
mRNA paclitaxel UHNBreast pan-cancer AAC -0.28 0.4
mRNA AZD6244 UHNBreast pan-cancer AAC -0.22 0.5
mRNA Sorafenib CCLE pan-cancer AAC -0.16 0.01
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.15 0.08
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.15 0.002
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.001
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.14 0.1
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.14 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.001
Download CSV